These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8914791)

  • 1. Towards gene therapy in the nervous system.
    Doering LC
    Clin Neurosci; 1995-1996; 3(5):259-61. PubMed ID: 8914791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in the development of herpes simplex virus-based gene transfer vectors for the nervous system.
    Fink DJ; Ramakrishnan R; Marconi P; Goins WF; Holland TC; Glorioso JC
    Clin Neurosci; 1995-1996; 3(5):284-91. PubMed ID: 8914795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapeutic strategies for neurodegenerative diseases.
    Baekelandt V; De Strooper B; Nuttin B; Debyser Z
    Curr Opin Mol Ther; 2000 Oct; 2(5):540-54. PubMed ID: 11249757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adeno-associated virus vectors for gene therapy of neurodegenerative disorders.
    During MJ; Leone P
    Clin Neurosci; 1995-1996; 3(5):292-300. PubMed ID: 8914796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Advance of gene therapy for neurological diseases by direct in vivo gene transfer].
    Li BY; Liu C; Wang HX
    Sheng Li Ke Xue Jin Zhan; 1996 Jul; 27(3):215-20. PubMed ID: 9772359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant AAV-mediated gene delivery to the central nervous system.
    Tenenbaum L; Chtarto A; Lehtonen E; Velu T; Brotchi J; Levivier M
    J Gene Med; 2004 Feb; 6 Suppl 1():S212-22. PubMed ID: 14978764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus for neurodegenerative diseases: in vivo strategies and ex vivo gene therapy using human neural progenitors.
    Sabaté O; Barkats M; Buc-Caron MH; Castel-Barthe MN; Finiels F; Horellou P; Revah F; Mallet J
    Clin Neurosci; 1995-1996; 3(5):317-21. PubMed ID: 8914799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gene therapy of neurologic diseases. Experimental approaches and clinical perspectives].
    Isenmann S; Bähr M; Dichgans J
    Nervenarzt; 1996 Feb; 67(2):91-108. PubMed ID: 8851291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of viral vectors to promote neuroregeneration.
    Verhaagen J; Hermens WT; Dijkhuizen PA; Holtmaat AJ; Gispen WH
    Clin Neurosci; 1995-1996; 3(5):275-83. PubMed ID: 8914794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nervous system modification by transplants and gene transfer.
    Doering LC
    Bioessays; 1994 Nov; 16(11):825-31. PubMed ID: 7840760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy for neurodegenerative diseases based on lentiviral vectors.
    Nanou A; Azzouz M
    Prog Brain Res; 2009; 175():187-200. PubMed ID: 19660657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy for neurodegenerative and ocular diseases using lentiviral vectors.
    Ralph GS; Binley K; Wong LF; Azzouz M; Mazarakis ND
    Clin Sci (Lond); 2006 Jan; 110(1):37-46. PubMed ID: 16336203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of gene therapy for the treatment of central nervous system tumors.
    Qureshi NH; Chiocca EA
    Crit Rev Oncog; 1999; 10(4):261-74. PubMed ID: 10654926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological, cell, and gene therapy strategies to promote spinal cord regeneration.
    Blits B; Boer GJ; Verhaagen J
    Cell Transplant; 2002; 11(6):593-613. PubMed ID: 12428749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vectors--shuttle vehicles for gene therapy.
    Wilson JM
    Clin Exp Immunol; 1997 Jan; 107 Suppl 1():31-2. PubMed ID: 9020933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vectors and delivery systems in gene therapy.
    Gardlík R; Pálffy R; Hodosy J; Lukács J; Turna J; Celec P
    Med Sci Monit; 2005 Apr; 11(4):RA110-21. PubMed ID: 15795707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual-promoter lentiviral vectors for constitutive and regulated gene expression in neurons.
    Gascón S; Paez-Gomez JA; Díaz-Guerra M; Scheiffele P; Scholl FG
    J Neurosci Methods; 2008 Feb; 168(1):104-12. PubMed ID: 17983662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential of gene therapy for Parkinson's disease: neurobiologic issues and new developments in gene transfer methodologies.
    Kang UJ
    Mov Disord; 1998; 13 Suppl 1():59-72. PubMed ID: 9613721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenovirus-mediated gene transfer to the central nervous system for Parkinson's disease.
    Horellou P; Sabaté O; Buc-Caron MH; Mallet J
    Exp Neurol; 1997 Mar; 144(1):131-8. PubMed ID: 9126162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.